Literature DB >> 8897512

Acquired resistance of merino sheep against Fasciola gigantica.

J A Roberts1, S Widjayanti, E Estuningsih.   

Abstract

Merino sheep acquired resistance against Fasciola gigantica, which is contrary to previous observations of infections with F. hepatica in that breed. The acquired resistance was manifest against young adult parasites. St. Croix sheep had previously been shown to have more resistance than European sheep against F. hepatica after primary infection; however, in F. gigantica infections in the present study there was no difference between the resistance levels of the breeds. Antigenic analysis of the host:parasite relationships could lead to identification of protective antigens suitable for use as vaccines.

Entities:  

Mesh:

Year:  1996        PMID: 8897512     DOI: 10.1007/s004360050196

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  3 in total

1.  Gastrointestinal helminthiasis: prevalence and associated determinants in domestic ruminants of district Toba Tek Singh, Punjab, Pakistan.

Authors:  Muhammad Nisar Khan; Muhammad Sohail Sajid; Muhammad Kasib Khan; Zafar Iqbal; Altaf Hussain
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

2.  Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica.

Authors:  David Piedrafita; Endah Estuningsih; Jill Pleasance; Rhoda Prowse; Herman W Raadsma; Els N T Meeusen; Terry W Spithill
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

3.  Effect of primary and secondary Fasciola gigantica infection on specific IgG responses, hepatic enzyme levels and weight gain in buffaloes.

Authors:  Jin-Hui Wang; Kang-Xin He; Zhen-Di Wang; Chong-Li Wen; Xiao-Ge Han; Zhen Meng; Xiang-Xiang Yuan; Zheng-Jiao Wu; Wei-Yu Zhang; Wen-Da Di
Journal:  Parasitol Res       Date:  2022-04-13       Impact factor: 2.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.